Lacrimal canalicular obstruction associated with topical ocular medication. 1998

A A McNab
Royal Victorian Eye and Ear Hospital, Melbourne, Australia. amcnab@medeserv.com.au

OBJECTIVE To describe the association between the use of various types of topical ocular medications and acquired lacrimal canalicular obstruction in 14 patients. METHODS The records of all patients in the author's practice with either lacrimal canalicular or punctal occlusion associated with the use of topical ocular medication were reviewed. RESULTS Fourteen cases were identified. The obstructions occurred at any point from the punctum to the common canaliculus, but most commonly occurred 2-5 mm from the lacrimal punctum. There was an association with various degrees of clinically apparent subconjunctival scarring maximal at the inner canthus, rarely to a severe degree, with symblepharon, medial canthal keratinization and cicatricial medial entropion. In some cases, no subconjunctival scarring could be clinically detected. Topical medications used were often multiple and included prednisolone acetate/phenylephrine hydrochloride (n = 5), timolol maleate (n = 5), pilocarpine (n = 3), dipivefrine hydrochloride or adrenaline (n = 3), chloramphenicol (n = 3), tobramycin (n = 3), indomethacin (n = 2), ecothiopate iodide (n = 1), betaxolol (n = 1), dexamethasone (n = 1), tropicamide (n = 1) and the long-term use of naphazoline and various artificial tear preparations (n = 1). The duration of exposure ranged from 3 weeks to 20 years, with seven patients having used drops for 3-6 weeks. Seven patients had surgical repair, three by dacryocystorhinostomy (DCR) and glass by-pass tube (all successful), three by canalicular repairs (one failed) and one by DCR and canalicular repair that restenosed at the puncta, who then had successful punctoplasty and silicone intubation. CONCLUSIONS Lacrimal canalicular obstruction may occur after relatively short-term exposure to topical ocular medications or as part of a more widespread cicatricial reaction in patients on long-term medication. While a direct causal relationship cannot be confirmed, there appears to be a strong association and the site of the obstructions makes other causes unlikely.

UI MeSH Term Description Entries
D007767 Lacrimal Duct Obstruction Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250) Nasolacrimal Duct Obstruction,Tear Duct Obstruction,Duct Obstruction, Lacrimal,Duct Obstruction, Nasolacrimal,Duct Obstruction, Tear,Lacrimal Duct Obstructions,Nasolacrimal Duct Obstructions,Obstruction, Lacrimal Duct,Obstruction, Nasolacrimal Duct,Obstruction, Tear Duct,Tear Duct Obstructions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008916 Miotics Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. Miotic Effect,Miotic Effects,Effect, Miotic,Effects, Miotic
D009301 Nasolacrimal Duct A tubular duct that conveys TEARS from the LACRIMAL GLAND to the nose. Lacrimal Sac,Tear Duct,Duct, Nasolacrimal,Duct, Tear,Ducts, Nasolacrimal,Ducts, Tear,Lacrimal Sacs,Nasolacrimal Ducts,Sac, Lacrimal,Sacs, Lacrimal,Tear Ducts
D009883 Ophthalmic Solutions Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. Eye Drop,Eyedrop,Eyedrops,Ophthalmic Solution,Eye Drops,Drop, Eye,Drops, Eye,Solution, Ophthalmic,Solutions, Ophthalmic
D003608 Dacryocystorhinostomy Surgical fistulization of the LACRIMAL SAC for external drainage of an obstructed nasolacrimal duct. Dacryocystostomy,Dacryocystorhinostomies,Dacryocystostomies
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A A McNab
January 1982, The British journal of ophthalmology,
A A McNab
June 2006, Orbit (Amsterdam, Netherlands),
A A McNab
October 2009, Journal of ophthalmic & vision research,
A A McNab
January 2022, ORL; journal for oto-rhino-laryngology and its related specialties,
A A McNab
January 1986, Indian journal of pediatrics,
A A McNab
December 2023, International ophthalmology,
A A McNab
January 2020, The Journal of craniofacial surgery,
A A McNab
February 2000, Acta ophthalmologica Scandinavica,
A A McNab
June 1985, The British journal of ophthalmology,
Copied contents to your clipboard!